NKGen Biotech (NKGN) Stock Chart & Stock Price History → Does this make you sick? (From Allegiance Gold) (Ad) Free NKGN Stock Alerts $1.12 -0.01 (-0.88%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media NKGen Biotech Stock Price Performance5 Day Performance-1.75%1 Month Performance+1.27%3 Month Performance-25.33%6 Month Performance-60.00%Year-To-Date Performance-59.27% Receive NKGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Awesomely, LLCAutomatic Income (from home)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…Watch this short video NKGN Stock Chart for Sunday, May, 19, 2024 NKGN Chart by TradingView NKGen Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$1.13$1.12-0.88%$1.15$1.1047,867 shs$25.20 million05/16/2024$1.14$1.13-0.88%$1.15$1.1251,077 shs$25.43 million05/15/2024$1.14$1.14$1.19$1.1252,752 shs$25.65 million05/14/2024$1.24$1.14-8.06%$1.25$1.12159,612 shs$25.64 million05/13/2024$1.26$1.24-1.59%$1.28$1.2262,291 shs$27.90 million05/10/2024$1.25$1.26+0.80%$1.32$1.2363,576 shs$28.34 million Get the Latest News and Ratings for NKGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$1.35$1.25-7.41%$1.34$1.22147,723 shs$28.12 million05/08/2024$1.29$1.35+4.65%$1.36$1.2749,031 shs$30.38 million05/07/2024$1.34$1.29-3.73%$1.33$1.28107,743 shs$29.03 million05/06/2024$1.43$1.34-6.29%$1.51$1.33128,292 shs$30.15 million05/03/2024$1.32$1.43+8.33%$1.55$1.32209,427 shs$32.18 million05/02/2024$1.46$1.32-9.59%$1.55$1.28244,201 shs$29.70 million05/01/2024$1.51$1.46-3.31%$1.53$1.42142,252 shs$33.30 million04/30/2024$1.64$1.51-7.93%$1.65$1.47439,593 shs$34.44 million04/29/2024$1.61$1.64+1.86%$1.90$1.623.26 million shs$37.40 million04/26/2024$1.98$1.61-18.69%$1.95$1.60543,810 shs$36.72 million04/25/2024$1.71$1.98+15.79%$2.11$1.652.06 million shs$45.16 million04/24/2024$1.85$1.71-7.57%$1.96$1.611.44 million shs$39.01 million04/23/2024$1.47$1.85+25.85%$1.95$1.5211.49 million shs$42.20 million04/22/2024$1.11$1.47+32.91%$1.72$1.2023.62 million shs$33.53 million04/19/2024$0.86$1.11+28.60%$1.62$0.834.88 million shs$25.23 million04/18/2024$1.03$0.86-16.50%$1.02$0.82349,360 shs$18.83 million04/17/2024$1.21$1.03-14.88%$1.13$1.02182,059 shs$22.55 million04/16/2024$1.24$1.21-2.42%$1.25$1.2052,241 shs$26.49 million04/15/2024$1.20$1.24+3.33%$1.27$1.2085,157 shs$27.14 million04/12/2024$1.28$1.20-6.25%$1.31$1.2085,115 shs$26.27 million04/11/2024$1.26$1.28+1.59%$1.33$1.25432,380 shs$28.02 million04/10/2024$1.31$1.26-3.82%$1.30$1.2288,383 shs$27.58 million04/09/2024$1.26$1.31+3.97%$1.32$1.22115,027 shs$28.68 million04/08/2024$1.38$1.26-8.70%$1.31$1.20157,401 shs$27.58 million04/05/2024$1.28$1.38+7.81%$1.46$1.20215,164 shs$30.21 million04/04/2024$1.55$1.28-17.42%$1.60$1.28442,698 shs$28.02 million04/03/2024$1.82$1.55-14.84%$1.80$1.53284,519 shs$33.93 million04/02/2024$1.95$1.82-6.67%$1.94$1.81202,771 shs$39.84 million04/01/2024$1.89$1.95+3.17%$1.98$1.87159,383 shs$42.68 million03/29/2024$1.89$1.89$1.91$1.70395,893 shs$41.37 million03/28/2024$1.80$1.89+5.00%$1.91$1.70394,440 shs$41.37 million03/27/2024$1.92$1.80-6.25%$1.90$1.79471,817 shs$39.40 million03/26/2024$2.16$1.92-11.11%$2.15$1.83863,825 shs$42.03 million03/25/2024$2.32$2.16-6.90%$2.57$2.001.47 million shs$47.28 millionweirdest stock market marches on (Ad)For the last few months, Graham Lindman has been urging investors to ignore virtually every stock on the exchange and only focus on the handful of “Apex Stocks” that produce all the wealth. And he sure seems to be right! Because while we’re in an extremely bullish market, it’s not because most companies are doing that well. It’s because a handful of wealth generating juggernauts are yanking the market to all time highs. That’s why this headline called it the “Weirdest bull market”Graham is hosting a “tell all” workshop about his Apex Indicator here03/22/2024$2.22$2.32+4.50%$2.54$2.211.43 million shs$50.79 million03/21/2024$2.19$2.22+1.37%$2.25$1.96831,386 shs$48.59 million03/20/2024$2.12$2.19+3.30%$2.47$2.131.85 million shs$47.94 million03/19/2024$1.97$2.12+7.61%$3.09$1.8722.03 million shs$46.41 million03/18/2024$1.96$1.97+0.51%$2.03$1.80561,962 shs$43.12 million03/15/2024$1.86$1.96+5.38%$2.05$1.76536,397 shs$42.90 million03/14/2024$1.97$1.86-5.58%$1.96$1.75328,409 shs$40.72 million03/13/2024$1.73$1.97+13.87%$2.09$1.78845,879 shs$43.12 million03/12/2024$2.56$1.73-32.42%$2.84$1.672.51 million shs$37.87 million03/11/2024$2.18$2.56+17.43%$3.10$2.239.78 million shs$56.04 million03/08/2024$1.93$2.18+12.95%$2.64$1.898.49 million shs$47.72 million03/07/2024$1.83$1.93+5.46%$2.35$1.7512.78 million shs$42.25 million03/06/2024$0.86$1.83+112.30%$4.06$1.16106.27 million shs$40.06 million03/05/2024$0.84$0.86+3.22%$0.99$0.85282,914 shs$18.87 million03/04/2024$0.85$0.84-1.64%$0.92$0.7887,254 shs$18.28 million03/01/2024$0.80$0.85+6.51%$0.85$0.8165,087 shs$18.59 million02/29/2024$0.80$0.80-0.37%$0.91$0.8047,989 shs$17.45 million02/28/2024$0.95$0.80-15.57%$0.99$0.80111,714 shs$17.51 million02/27/2024$0.97$0.95-2.08%$1.00$0.9511,721 shs$20.74 million02/26/2024$1.00$0.97-3.23%$1.04$0.9527,789 shs$21.18 million02/23/2024$1.00$1.00$1.00$0.9917,120 shs$21.89 million02/22/2024$0.95$1.00+5.22%$1.06$0.9936,993 shs$21.89 million02/21/2024$1.26$0.95-24.57%$1.27$0.94152,843 shs$20.80 million02/20/2024$1.50$1.26-16.00%$1.50$1.2565,961 shs$27.58 million02/19/2024$1.50$1.50$1.54$1.4815,300 shs$32.84 million Related Companies: Cortexyme Stock Price Chart ZIVO Bioscience Stock Price Chart Evaxion Biotech A/S Stock Price Chart Aptose Biosciences Stock Price Chart AIM ImmunoTech Stock Price Chart PharmaCyte Biotech Stock Price Chart Surrozen Stock Price Chart Senti Biosciences Stock Price Chart Brainstorm Cell Therapeutics Stock Price Chart Pluri Stock Price Chart Receive NKGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NKGN) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.